Communicating Drug Safety and Safe Use Conditions in Risk Evaluation and Mitigation Strategy Materials.
- DOI
- 10.1007/s40264-026-01721-2
- Published
- 2026 Sep 2
- Container
- Drug safety
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s40264-026-01721-2,
title = {Communicating Drug Safety and Safe Use Conditions in Risk Evaluation and Mitigation Strategy Materials.},
author = {Sarpatwari A and Tessema FA and Mitra-Majumdar M and Lee SB and Zakoul H and Brown BL and Toyserkani GA and Oswell KH and LaCivita C and Dal Pan GJ and Woloshin S and Avorn J and Kesselheim AS},
year = {2026},
journal = {Drug safety},
doi = {10.1007/s40264-026-01721-2},
url = {https://doi.org/10.1007/s40264-026-01721-2}
}RIS
TY - JOUR TI - Communicating Drug Safety and Safe Use Conditions in Risk Evaluation and Mitigation Strategy Materials. AU - Sarpatwari A AU - Tessema FA AU - Mitra-Majumdar M AU - Lee SB AU - Zakoul H AU - Brown BL AU - Toyserkani GA AU - Oswell KH AU - LaCivita C AU - Dal Pan GJ AU - Woloshin S AU - Avorn J AU - Kesselheim AS PY - 2026 JO - Drug safety DO - 10.1007/s40264-026-01721-2 UR - https://doi.org/10.1007/s40264-026-01721-2 ER -
APA
A, S., FA, T., M, M., SB, L., H, Z., BL, B., GA, T., KH, O., C, L., GJ, D. P., S, W., J, A., & AS, K. (2026). Communicating Drug Safety and Safe Use Conditions in Risk Evaluation and Mitigation Strategy Materials.. Drug safety. https://doi.org/10.1007/s40264-026-01721-2
Source records
- pubmed · retrieved 2026-09-26T15:12:33.782Z
- europe-pmc · retrieved 2026-09-26T15:12:33.770Z